Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-011757
Filing Date
2012-11-14
Accepted
2012-11-14 16:46:15
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rbm_10q-093012.htm 10-Q 939578
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13849
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14173
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7264
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6587
  Complete submission text file 0001437749-12-011757.txt   5179205

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE rpbif-20120930.xml EX-101.INS 842995
7 XBRL TAXONOMY EXTENSION rpbif-20120930.xsd EX-101.SCH 44435
8 XBRL TAXONOMY EXTENSION CALCULATION rpbif-20120930_cal.xml EX-101.CAL 29251
9 XBRL TAXONOMY EXTENSION DEFINITION rpbif-20120930_def.xml EX-101.DEF 239541
10 XBRL TAXONOMY EXTENSION LABEL rpbif-20120930_lab.xml EX-101.LAB 287775
11 XBRL TAXONOMY EXTENSION PRESENTATION rpbif-20120930_pre.xml EX-101.PRE 240245
Mailing Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2
Business Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2 604-456-6010
RESPONSE BIOMEDICAL CORP (Filer) CIK: 0000806888 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50571 | Film No.: 121205428
SIC: 8734 Services-Testing Laboratories